The authors hypothesized that among extremely preterm infants, elevated concentrations of inflammation-related proteins in neonatal blood are associated with cerebral palsy at 24 months. In 939 infants born before 28 weeks gestation, the authors measured blood concentrations of 25 proteins on postnatal days 1, 7, and 14 and evaluated associations between elevated protein concentrations and cerebral palsy diagnosis. Protein elevations within 3 days of birth were not associated with cerebral palsy. Elevations of tumor necrosis factor-a, tumor necrosis factor-a-receptor-1, interleukin-8, and intercellular adhesion molecule-1 on at least 2 days were associated with diparesis. Recurrent-persistent elevations of interleukin-6, E-selectin, or insulin-like growth factor binding protein-1 were associated with hemiparesis. Diparesis and hemiparesis were more likely among infants who had at least 4 of 9 protein elevations that previously have been associated with cognitive impairment and microcephaly. Repeated elevations of inflammation-related proteins during the first 2 postnatal weeks are associated with increased risk of cerebral palsy.
Among infants born preterm, elevated concentrations of inflammation-related proteins in umbilical cord and neonatal blood are associated with neonatal cerebral white matter damage, [1] [2] [3] which, in turn, is associated with subsequent diagnosis of cerebral palsy. 4, 5 Studies of these associations have been limited by small samples, selection of children based on birth weight rather than gestational age, measurement of a small number of proteins at a single time, nonstandard methods for diagnosing cerebral palsy, and aggregation of heterogeneous forms of cerebral palsy into a single outcome.
In a prospective study of infants born before the 28th week of gestation, the authors measured concentrations of 25 inflammation-related proteins in blood samples from nearly a thousand newborns within 3 days of birth and approximately 1 week and 2 weeks later. Elevated concentrations of 10 of these proteins (C-reactive protein, serum amyloid A, interleukin-1b, interleukin-6, interleukin-8, tumor necrosis factor-a, macrophage inflammatory protein-1b, intercellular adhesion molecule-1, E-selectin, and insulin-like growth factor binding protein-1) on 2 days a week or more apart were associated with an increased risk of severe early cognitive impairment (Mental Developmental Index <55 on the Bayley Scales of Infant Development II) 6 and microcephaly 7 but not when the elevated concentration occurred on a single day. 6, 7 In this report, the authors describe the relationships between elevated concentrations of inflammation-associated proteins and cerebral palsy form-hemiparetic, diparetic, or quadriparetic. of structural and functional neurological disorders in newborns of extremely low gestational age. During the years 2002-2004, women delivering before 28 weeks gestation at 1 of 14 institutions in 11 cities in 5 states were asked to enroll in the study. The enrollment and consent processes were approved by the individual institutional review boards.
Mothers were approached for consent either upon antenatal admission or shortly after delivery, depending on clinical circumstance and institutional preference. Consent was granted by 1249 mothers of 1506 infants; 939 children from whom blood specimens were collected during the first 2 postnatal weeks for biomarker analyses were examined at approximately 24 months post-term equivalent.
Newborn Variables
The gestational age estimates were based on a hierarchy of the quality of available information. Most desirable were estimates based on the dates of embryo retrieval or intrauterine insemination or fetal ultrasound before the 14th week (62%). When these were not available, reliance was placed sequentially on a fetal ultrasound at 14 or more weeks (29%), last menstrual period (7%), and gestational age recorded in the log of the neonatal intensive care unit (1%).
Each infant was assigned a birth weight Z score, which represents the number of standard deviations the infant's birth weight was above or below the median weight of infants at the same gestational age in a standard data set.
Cerebral Palsy
Eleven percent of children evaluated at 24 months were diagnosed with quadriparetic, diparetic, or hemiparetic cerebral palsy. 8 Risk factors and correlated clinical outcomes differ for these 3 forms of cerebral palsy. [8] [9] [10] Blood Protein Measurements Drops of whole blood were collected on filter paper (Schleicher & Schuell 903) on the first postnatal day (range, 1-3 days), the 7th postnatal day (range, 5-8 days), and the 14th postnatal day (range, 12-15 days). Twenty-five proteins were measured in the Laboratory of Genital Tract Biology, Brigham and Women's Hospital, using the Meso Scale Discovery multiplex platform and Sector Imager 2400 (Meso Scale Discovery, Gaithersburg, Maryland), which has been validated against enzymelinked immunosorbent assay. Details about the procedure for processing the blood spots and for measuring protein concentrations and absolute value ranges for proteins are explained elsewhere. 6, 11 
Data Analysis
Since protein concentrations varied with gestational age at delivery and with the postnatal day of collection, the sample was divided into 9 groups defined by gestational age category (23-24, 25-26, and 27 weeks) and the 3 postnatal days of blood collection. Because the concentrations of most proteins did not follow a normal distribution, the concentration distribution of each protein was dichotomized into the highest quartile and the lower 3 quartiles for each of the 9 gestational age-postnatal day groups.
The following 3 null hypotheses were evaluated. First, infants with an elevated concentration (ie, in the top quartile for gestational age) of an inflammation-related protein on a specific day (days 1, 7, or 14) were not at higher risk of any form of cerebral palsy than infants whose concentration of that protein was in the lower 3 quartiles on that day. Second, infants with elevated concentrations of a single inflammation-related protein on 2 or more days (referred to here as a ''recurrent-persistent protein elevation'') were not at higher risk for cerebral palsy than infants without a recurrent-persistent protein elevation. Third, the risk of cerebral palsy did not vary with the number of proteins whose concentrations were in the highest quartile on 2 or more days. To test this hypothesis, the authors compared children who had 1, 2-3, or 4þ proteins with concentrations in the top quartile on 2 days with children who did not have any protein with concentrations in the top quartile on 2 days. Analyses were limited to the 9 proteins (interleukin-6, tumor necrosis factor-a, tumor necrosis factor-a-receptor-1, interleukin-8, intercellular adhesion molecule-1, E-selectin, C-reactive protein, serum amyloid A, and insulin-like growth factor binding protein-1) whose recurrently elevated concentrations were associated with increased risk of severe early cognitive impairment, 7 microcephaly, 7 and cerebral palsy.
The strength of association between each cerebral palsy diagnosis and a protein concentration in the highest quartile is presented as a risk ratio and its 99% confidence interval. This confidence interval, rather than the conventional 95% interval, was selected to account for multiple comparisons (25 proteins measured at 3 times), while not appreciably increasing the risk of a type 2 (false-negative) error. Because the outcomes are mutually exclusive and each is appropriately compared with the same referent group (ie, children who did not have a cerebral palsy diagnosis), the authors created multinomial (polytomous or polychotomous) logistic regression models (Stata 13.0, StataCorp, College Station, Texas).
Results

Sample Description
In this cohort, 105 children were classified as having cerebral palsy. Fifty-two percent were classified as having quadriparesis (n ¼ 55), 30% as having diparesis (n ¼ 32), and 17% as having hemiparesis (n ¼ 18). All forms of cerebral palsy were associated with low Psychomotor Developmental Index and Mental Developmental Index scores on the Bayley Scales of Infant Development II and with microcephaly. Children with diparesis were less likely than children with quadriparesis or hemiparesis to have other clinical indicators of brain damage or dysfunction.
Single-Day Elevated Protein Concentrations
None of the 25 proteins evaluated had a day-1 elevated concentration associated with any cerebral palsy diagnosis. On day 7, interleukin-6 receptor was the only protein whose elevated concentration was associated with reduced risk of quadriparesis, whereas monocyte chemotactic protein-1 was the only protein whose elevated concentration was associated with increased risk of quadriparesis. No protein elevation on day 7 was associated with increased or reduced risk of diparesis or hemiparesis.
On day 14, interleukin-6 receptor continued to be the only protein whose elevated concentration was associated with reduced risk of quadriparesis. Intercellular adhesion molecule-1 was the only protein whose elevated day 14 concentration was associated with increased risk of diparesis, while elevated concentrations of interleukin-6, E-selectin, and insulin-like growth factor binding protein-1 on day 14 were associated with increased risk of hemiparesis.
Multiple-Day Elevated Individual Protein Concentrations
Elevated concentrations on 2 occasions of 2 proteins, interleukin-8 and monocyte chemotactic protein-1, were associated with increased risk of quadriparesis, and repeated interleukin-6 receptor elevation was associated with reduced risk ( Table 1 ). Elevated concentrations of 4 proteins, tumor necrosis factor-a, tumor necrosis factor-a-receptor-1, interleukin-8, and intercellular adhesion molecule-1, were associated with increased risk of diparesis, while a different set of 4 protein elevations, interleukin-6, interleukin-8, E-selectin, and insulin-like growth factor binding protein-1, were associated with increased risk of hemiparesis. These elevated concentrations were much more likely to be seen on days 7 and 14 than on the first postnatal day (data not shown).
Multiple-Day Elevations of Multiple Proteins
The risks of diparesis and of hemiparesis were significantly increased when at least 4 of the 10 proteins associated with severe early cognitive impairment and microcephaly were in the highest quartile ( Table 2 ).
Discussion
Elevated blood concentrations of inflammation-related proteins during the first 2 postnatal weeks were associated, to varying degrees, with the diagnosis of each form of cerebral palsy. No single-day elevation of any inflammation-related protein observed within 3 days of birth was associated with a diagnosis of quadriparesis, diparesis, or hemiparesis in our study.
Subacute/Chronic Inflammation
Elevated protein concentrations on more than 1 day were associated with increased risk of cerebral palsy, but transient elevations were not. These findings suggest that systemic inflammation persisting or recurring over at least 2 early postnatal weeks is more important than transient elevations of inflammatory proteins. This pattern of stronger associations with persisting or recurring inflammation, rather than with transient inflammation, has been found also for severe early cognitive impairment 6 and microcephaly. 7 Although the most likely inference is that recurrent or persistent inflammation is Values are risk ratios (99% confidence intervals) of the form of cerebral palsy associated with a protein concentration in the top quartile (for gestational age and day specimen was obtained) of the protein listed on the left on 2 separate days at least a week apart relative to that of children who did not have cerebral palsy. The sample for this table consists of all children with blood measurements on 2 days. These were multinomial analyses with children who did not have cerebral palsy as the referent group and are adjusted for gestational age. b Significantly elevated at P < .01.
c Significantly low at P < .01.
needed to injure the brain, it is also possible that systemic inflammation is a consequence of ongoing brain damage. 12 It is not known how much of the persistence of elevated concentrations reflects a long half-life and how much reflects continued synthesis in response to new or persistent inflammatory stimuli, such as prolonged ventilation 13 or bacteremia. 14 Although the half-life of circulating inflammation-associated cytokines is short in adult rabbits and rodents, 15 the half-life in preterm human newborns remains unknown. 16 In the ELGAN cohort, persistently and recurrently elevated protein concentrations tended to occur on days 7 and 14. This observation is consistent with the notion that postnatal events contribute to risk of cerebral palsy.
Is Inflammation a Cause or a Consequence of Cerebral Palsy-Related Brain Damage?
The presence of high concentrations of inflammationassociated proteins in neonates who later develop adverse neurological outcomes might reflect primarily the process of clearing away damaged brain cells. 17 Nonetheless, such inflammation-resolution processes can promote feedbackloops between brain damage and the immune system, 18 further enhancing the degree of neurological damage, 19 which in turn can heighten inflammation and perpetuate braindamaging processes. In this model, perinatal brain damage is an ongoing process and what was measured in the current study might actually contribute to damage and the risk of such adverse outcomes as cerebral palsy. 12 Consequently, the elevated concentrations of inflammation-related proteins might convey information about both the processes leading to brain damage and the risk of later dysfunctions. Whether systemic inflammation actually contributes to brain damage in human newborns remains to be documented, although evidence suggests that it does in adult humans and rodents. 20 White matter abnormalities found on perinatal cranial ultrasound studies are highly associated with both elevated proinflammatory peptides 21 and cerebral palsy. 22 The authors do not know when the white matter abnormalities developed in the ELGAN cohort and thus cannot know the relative contribution, if any, of white matter abnormalities and systemic inflammation in the pathogenesis of cerebral palsy in this cohort.
Why Are Selected Multiple Proteins Associated With Cerebral Palsy Risk?
The proteins identified in the current study also have been associated previously with increased risks of neurological impairments, including stroke, cerebral palsy, and cognitive impairments. 4, [23] [24] [25] [26] [27] [28] [29] When the role of these proteins in predicting cerebral palsy was evaluated, the risk was found to be related to the number of protein elevations, which became significant when at least 4 of the circulating proteins were elevated. This observation suggests that the breadth of the inflammatory response, represented by the number of elevated inflammation-related protein concentrations among those evaluated, is associated with increased risk of brain damage and consequent adverse neurological outcomes, including cerebral palsy.
Inflammation-related proteins tend to be highly interrelated, with an inflammatory stimulus increasing the expression of hundreds of proteins. 30 Indeed, in the current sample, the concentrations of most of the 25 proteins assessed tended to vary compared with one another. 31 Although a portion of the organ damage that accompanies sepsis is attributed to a ''cytokine storm,'' 32 for the most part the subjects in the current study did not have life-threatening sepsis, nor did most children have damage to multiple organs. 33 Consequently, explosive, potentially fatal inflammation is probably not a suitable model for what is seen here. Rather, a slower subacute or chronic set of inflammatory processes may be more consistent with the present findings. The small number of proteins whose elevated concentrations were most clearly associated with a form of cerebral palsy might reflect the concept that a small subset of inflammationrelated proteins are especially relevant to brain damage in extremely preterm newborns. 11 It is also possible that a larger number of proteins would have been found elevated in the ELGAN children if blood sampling had been extended beyond 2 weeks after birth. The 2 cytokines, interleukin-6 and tumor necrosis factor-a, are often the primary initiators of inflammatory cascades via nuclear factor-kB, in response to environmental cues. Also, interleukin-8, intercellular adhesion molecule-1, and E-selectin are among the earliest secondary responders to inflammatory stimulation: Values are risk ratios (95% confidence intervals) for each form of cerebral palsy associated with elevated concentrations of the number of proteins identified at the top of each column on 2 separate days a week apart. The 9 proteins are interleukin-6, tumor necrosis factor-a, tumor necrosis factor-a-receptor-1, interleukin-8, intercellular adhesion molecule-1, E-selectin, C-reactive protein, serum amyloid A, and insulin-like growth factor binding protein-1. The referent category (identified with an odds ratio of 1.0) consists of all children who did not have any protein with a concentration in the top quartile on any 2 days. b Significantly elevated at P < .05.
for example, via interleukin-6 and tumor necrosis factor-a. Elevations of soluble interleukin-6 and tumor necrosis factor-a receptors show contrasting effects. While soluble tumor necrosis factor-a-receptor-1 may extend the half-life of tumor necrosis factor-a, thus contributing to inflammation, the role of soluble interleukin-6 receptor in inflammation is more controversial and complex. 34 
Postnatal, Not Prenatal Inflammation
In this sample, elevated concentrations on day 1 were associated with spontaneous indications for delivery, 35 histological inflammation of the placenta, 36 and recovery of organisms from placenta parenchyma, 37 suggesting that day 1 elevations reflect prenatal influences. The finding that early protein elevations appear to be less predictive of cerebral palsy risk in newborns of extremely low gestational age than are protein elevations at 1 and 2 postnatal weeks suggests that postnatal events contribute appreciably to risk for long-term neurological impairments, while antenatal phenomena contribute considerably less.
Heterogeneity of Cerebral Palsy
The stronger association of elevated protein concentrations with hemiparetic and diparetic forms of cerebral palsy than with quadriparetic cerebral palsy suggests that the pathophysiological process differs among cerebral palsy forms. This possibility prompted the investigators to distinguish different forms of cerebral palsy in the analyses. 8 Exposure to higher concentrations of inflammationassociated proteins in ventricular or transependymal cerebrospinal fluid might account for the predilection for damage to the periventricular white matter fibers subserving lower extremities seen in diparetic cerebral palsy. 38 Other mechanisms, involving genetic or epigenetic-associated risks, 39, 40 might have a stronger role in contributing to the risk in certain forms of cerebral palsy, such as quadriparesis. The relatively small number of children with hemiparesis limits the inferences that might be drawn about contributory risks.
The findings imply that the risk of brain damage in extremely preterm infants might be influenced by both the occurrence of inflammation-related illnesses and the severity of the systemic inflammation that accompanies such illnesses. 41 For this reason, and because the effects of inflammation on synaptic integrity, 42, 43 plasticity, [43] [44] [45] [46] oligodendroglia cell survival, 47 and dysregulated apoptosis 48 might extend over months to years, the therapeutic window for intervention might also be longer than the immediate postnatal period. 49 
Strengths of This Study
The study has several strengths. First, a large number of infants were included. Second, to minimize confounding due to factors related to fetal growth restriction, infants were recruited based on gestational age and not birth weight. Third, the data were collected prospectively. Fourth, attrition in the first 2 years was modest, with neurological outcomes established in almost 90% of surviving infants. Fifth, examiners at 2 years were not aware of the medical histories of the children they examined, thereby minimizing ''diagnostic suspicion bias.'' Sixth, observer variability in assessments of motor function was minimized. Seventh, a structured objective algorithm was used to classify cerebral palsy subtypes. 8 Eighth, the protein data are of high quality and have high content validity. 11, 35, 37 
Limitations of this Study
As with all observational studies, the authors are unable to distinguish between causation and association as explanations for what was found. Second, the small numbers of children with each of the 3 cerebral palsy forms limit the power of the analyses. Third, although a wide range of inflammation-associated proteins were sampled, including specific proteins known to be associated with neurological damage, not all known inflammation-associated proteins were evaluated. The proteins measured were selected on the basis of their likely involvement in the fetal/neonatal inflammatory response and the accuracy with which they could be measured within linearity ranges using the Meso Scale Discovery multiplex platform.
Conclusion
Extremely preterm newborns who have repeatedly elevated concentrations of a number of inflammation-related proteins in their blood during the first 2 postnatal weeks are at increased risk of a cerebral palsy diagnosis 2 years later. This conclusion carries implications for clinical practice, including extending clinical interventions beyond the conventional postnatal period.
